Patient Leaflet Updated 08-Dec-2022 | Novo Nordisk Limited
Tresiba 200 units/mL Pre-filled Pen (FlexTouch)
Tresiba® 200 units/mL solution for injection in pre-filled pen
insulin degludec
1. What Tresiba® is and what it is used for
2. What you need to know before you use Tresiba®
3. How to use Tresiba®
4. Possible side effects
5. How to store Tresiba®
6. Contents of the pack and other information
Tresiba® is a long-acting basal insulin called insulin degludec. It is used to treat diabetes mellitus in adults, adolescents and children aged 1 year and above. Tresiba® helps your body reduce your blood sugar level. It is used for once-daily dosing. On occasions when you cannot follow your regular dosing schedule, you can change the time of dosing because Tresiba® has a long blood sugar-lowering effect (see section 3 for ‘Flexibility in dosing time’). Tresiba® can be used with meal-related rapid-acting insulin products. In type 2 diabetes mellitus, Tresiba® may be used in combination with tablets for diabetes or with injectable antidiabetic medicines, other than insulin.
In type 1 diabetes mellitus, Tresiba® must always be used in combination with meal-related rapid- acting insulin medicines.
Talk to your doctor, pharmacist or nurse before using Tresiba®. Be especially aware of the following:
If you have poor eyesight, please see section 3.
The injection site should be rotated to help prevent changes to the fatty tissue under the skin, such as skin thickening, skin shrinking or lumps under the skin. The insulin may not work very well if you inject into a lumpy, shrunken or thickened area (see section 3 ‘How to use Tresiba®’). Tell your doctor if you notice any skin changes at the injection site. Tell your doctor if you are currently injecting into these affected areas before you start injecting in a different area. Your doctor may tell you to check your blood sugar more closely, and to adjust your insulin or your other antidiabetic medications dose.
Tresiba® can be used in adolescents and children aged 1 year and above. There is no experience with the use of Tresiba® in children below the age of 1 year.
Tell your doctor, pharmacist or nurse if you are taking, have recently taken or might take any other medicines. Some medicines affect your blood sugar level, this may mean your insulin dose has to be changed.
Listed below are the most common medicines which may affect your insulin treatment.
Your blood sugar level may fall (hypoglycaemia) if you take:
Your blood sugar level may rise (hyperglycaemia) if you take:
Octreotide and lanreotide: used to treat a rare condition involving too much growth hormone (acromegaly). They may increase or decrease your blood sugar level.
Pioglitazone: oral antidiabetic medicine used to treat type 2 diabetes mellitus. Some patients with long-standing type 2 diabetes mellitus and heart disease or previous stroke who were treated with pioglitazone and insulin experienced the development of heart failure. Inform your doctor immediately if you experience signs of heart failure such as unusual shortness of breath, rapid increase in weight or localised swelling (oedema).
If any of the above applies to you (or you are not sure), talk to your doctor, pharmacist or nurse.
If you drink alcohol, your need for insulin may change. Your blood sugar level may either rise or fall. You should therefore monitor your blood sugar level more often than usual.
If you are pregnant or breast-feeding, think you may be pregnant or are planning to have a baby, ask your doctor or pharmacist for advice before taking this medicine. Your insulin dose may need to be changed during pregnancy and after delivery. Careful control of your diabetes is needed in pregnancy.
Avoiding too low blood sugar (hypoglycaemia) is particularly important for the health of your baby.
Having too low or too high blood sugar can affect your ability to drive or use any tools or machines. If your blood sugar is too low or too high, your ability to concentrate or react might be affected. This could be dangerous to yourself or others. Ask your doctor whether you can drive if:
This medicine contains less than 1 mmol sodium (23 mg) per dose. This means that the medicine is essentially ‘sodium-free’.
Always use this medicine exactly as your doctor has told you. Check with your doctor, pharmacist or nurse if you are not sure.
If you are blind or have poor eyesight and cannot read the dose counter on the pen, do not use this pen without help. Get help from a person with good eyesight who is trained to use the FlexTouch® pre-filled pen.
Tresiba® in a pre-filled pen is available in two strengths. “Tresiba® 100 units/mL” or “Tresiba® 200 units/mL” is clearly marked on the pen label and packaging. In addition, Tresiba® 100 units/mL packaging and label are light green, and Tresiba® 200 units/mL packaging and label are dark green with striping with a red box highlighting the formulation strength.
For both strengths, the needed dose is dialled in units. The dose steps, however, differ between the two strengths of Tresiba®.
The pre-filled pen 200 units/mL can provide a dose of 2–160 units in one injection in steps of 2 units.
The dose counter of the pre-filled pen shows the number of units of insulin to be injected. Do not make any dose re-calculation.
Based on your blood sugar level, your doctor may change your dose.
When using other medicines, ask your doctor if your treatment needs to be adjusted.
Tresiba® can be used in elderly, but if you are elderly, you may need to check your blood sugar level more often. Talk to your doctor about changes in your dose.
If you have kidney or liver problems, you may need to check your blood sugar level more often. Talk to your doctor about changes in your dose.
Before you use Tresiba® for the first time, your doctor or nurse will show you how to use the pre-filled pen.
Detailed instructions for use are provided on the other side of this leaflet.
If you use too much insulin, your blood sugar may get too low (hypoglycaemia), see advice in section 4 ‘Too low blood sugar’.
If you forget a dose, inject the missed dose when discovering the mistake, ensuring a minimum of 8 hours between doses. If you discover that you missed your previous dose when it is time to take your next regular scheduled dose, do not inject a double dose, but resume your once-daily dosing schedule.
Do not stop using your insulin without talking to your doctor. If you stop using your insulin, this could lead to a very high blood sugar level and ketoacidosis (a condition with too much acid in the blood), see advice in section 4 ‘Too high blood sugar’.
Like all medicines, this medicine can cause side effects, although not everybody gets them.
Hypoglycaemia (too low blood sugar) may occur very commonly with insulin treatment (may affect more than 1 in 10 people). It can be very serious. If your blood sugar level falls too much, you may become unconscious. Serious hypoglycaemia may cause brain damage and may be life-threatening. If you have symptoms of low blood sugar, take actions to increase your blood sugar level immediately. See advice in ‘Too low blood sugar’ below.
If you have a serious allergic reaction (seen rarely) to the insulin or any of the ingredients in Tresiba®, stop using this medicine and see a doctor straight away. The signs of a serious allergic reaction are:
If you inject insulin at the same place, the fatty tissue may shrink (lipoatrophy) or thicken (lipohypertrophy) (may affect up to 1 in 100 people ). Lumps under the skin may also be caused by build-up of a protein called amyloid (cutaneous amyloidosis; how often this occurs is not known). The insulin may not work very well if you inject into a lumpy, shrunken or thickened area. Change the injection site with each injection to help prevent these skin changes.
Other side effects include:
Common (may affect up to 1 in 10 people)
Local reactions: Local reactions at the place you inject yourself may occur. The signs may include: pain, redness, hives, swelling and itching. The reactions usually disappear after a few days. See your doctor if they do not disappear after a few weeks. Stop using Tresiba® and see a doctor straight away if the reactions become serious. For more information, see ‘serious allergic reaction’ above.
Uncommon (may affect up to 1 in 100 people)
Swelling around your joints: When you first start using your medicine, your body may keep more water than it should. This causes swelling around your ankles and other joints. This is usually only short-lasting.
Rare (may affect up to 1 in 1,000 people)
This medicine can cause allergic reactions such as hives, swelling of the tongue and lips, diarrhoea, nausea, tiredness and itching.
drink alcohol; use too much insulin; exercise more than usual; eat too little or miss a meal.
Headache; slurred speech; fast heartbeat; cold sweat, cool pale skin; feeling sick, feeling very hungry; tremor or feeling nervous or worried; feeling unusually tired, weak and sleepy; feeling confused, difficulty in concentrating; short-lasting changes in your sight.
Tell everyone you spend time with that you have diabetes. Tell them what could happen if your blood sugar gets too low, including the risk of passing out.
Let them know that if you pass out, they must:
You may recover more quickly from passing out with an injection of glucagon. This can only be given by someone who knows how to use it.
This is because the dosing or timing of your insulin injections, food or exercise may need to be changed.
eat more or exercise less than usual; drink alcohol; get an infection or a fever; have not used enough insulin; keep using less insulin than you need; forget to use your insulin or stop using insulin without talking to your doctor.
Flushed, dry skin; feeling sleepy or tired; dry mouth, fruity (acetone) breath; urinating more often, feeling thirsty; losing your appetite, feeling or being sick (nausea or vomiting).
These may be signs of a very serious condition called ketoacidosis. This is a build-up of acid in the blood because the body is breaking down fat instead of sugar. If not treated, this could lead to diabetic coma and eventually death.
If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via
Great Britain
or search for MHRA Yellow Card in the Google Play or Apple App Store.
By reporting side effects you can help provide more information on the safety of this medicine.
Keep this medicine out of the sight and reach of children.
Do not use this medicine after the expiry date which is stated on the pen label and carton, after ‘EXP’.
The expiry date refers to the last day of that month.
Store in a refrigerator (2°C to 8°C). Do not freeze. Keep away from the freezing element. Keep the cap on the pen in order to protect it from light.
You can carry your Tresiba® pre-filled pen (FlexTouch®) with you and keep it at room temperature (not above 30°C) or in a refrigerator (2°C to 8°C) for up to 8 weeks.
Always keep the cap on the pen when you are not using it in order to protect it from light.
Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how to throw away medicines you no longer use. These measures will help protect the environment.
Tresiba® is presented as a clear and colourless solution for injection in a pre-filled pen (600 units per 3 mL).
Pack sizes of 1 (with or without needles), 2 (without needles), 3 (without needles), 5 (without needles) and multipack of 6 (2 x 3) (without needles) pre-filled pens of 3 mL. Not all pack sizes may be marketed.
This leaflet was last revised in 10/2022
Tresiba®, FlexTouch®, NovoFine® and NovoTwist® are trademarks owned by Novo Nordisk A/S, Denmark
© 2022
Novo Nordisk A/S
Please read these instructions carefully before using your FlexTouch® pre-filled pen. If you do not follow the instructions carefully, you may get too little or too much insulin, which can lead to too high or too low blood sugar level.
Do not use the pen without proper training from your doctor or nurse.
Start by checking your pen to make sure that it contains Tresiba® 200 units/mL.
Different parts of your pen include:
Pen cap
Insulin scale
Insulin window
Pen label
Dose counter
Dose pointer
Dose Selector
Dose Button (with 2 dots indicates 2 units per step)
Different parts of your needle include:
Outer needle cap
Inner needle cap
Needle
Paper tab
If you are blind or have poor eyesight and cannot read the dose counter on the pen, do not use this pen without help. Get help from a person with good eyesight who is trained to use the FlexTouch® pre-filled pen.
Your pen is a pre-filled dial-a-dose insulin pen containing 600 units of insulin. You can select a maximum of 160 units per dose, in steps of 2 units. The dose counter of your pen shows the exact number of insulin units. Do not make any dose re-calculation. Your pen is designed to be used with NovoTwist® or NovoFine® single-use disposable needles up to a length of 8 mm.
Pay special attention to these notes as they are important for correct use of the pen.
Always use a new needle for each injection.
This reduces the risk of contamination, infection, leakage of insulin, blocked needles and inaccurate dosing.
Never use a bent or damaged needle.
A small air bubble may remain at the needle tip, but it will not be injected.
If no drop appears, repeat step 2 up to 6 times. If there is still no drop, change the needle and repeat step 2 once more.
If a drop of insulin still does not appear, dispose of the pen and use a new one.
Always make sure that a drop appears at the needle tip before you inject. This makes sure that the insulin flows.
If no drop appears, you will not inject any insulin, even though the dose counter may move. This may indicate a blocked or damaged needle.
Always check the flow before you inject. If you do not check the flow, you may get too little insulin or no insulin at all. This may lead to too high blood sugar level.
If you select a wrong dose, you can turn the dose selector forwards or backwards to the correct dose.
The pen can dial up to a maximum of 160 units.
The dose selector changes the number of units. Only the dose counter and dose pointer will show how many units you select per dose.
You can select up to 160 units per dose. When your pen contains less than 160 units, the dose counter stops at the number of units left.
The dose selector clicks differently when turned forwards, backwards or past the number of units left.
Do not count the pen clicks.
Always use the dose counter and the dose pointer to see how many units you have selected before injecting the insulin.
Do not count the pen clicks. If you select and inject the wrong dose, your blood sugar level may get too high or too low.
Do not use the insulin scale, it only shows approximately how much insulin is left in your pen.
You may see a drop of insulin at the needle tip after injecting. This is normal and does not affect your dose.
Always watch the dose counter to know how many units you inject.
The dose counter will show the exact number of units. Do not count the pen clicks. Hold the dose button down until the dose counter returns to 0 after the injection. If the dose counter stops before it returns to 0, the full dose has not been delivered, which may result in too high blood sugar level.
Always dispose of the needle after each injection in an appropriate sharps container. This reduces the risk of contamination, infection, leakage of insulin, blocked needles and inaccurate dosing. If the needle is blocked, you will not inject any insulin.
When the pen is empty, throw it away without a needle on as instructed by your doctor, nurse, pharmacist or local authorities. Do not place the used needle in household waste.
Never try to put the inner needle cap back on the needle. You may stick yourself with the needle.
Always remove the needle after each injection and store your pen without the needle attached.
This reduces the risk of contamination, infection, leakage of insulin, blocked needles and inaccurate dosing.
Be very careful to calculate correctly if splitting your dose.
If in doubt, take the full dose with a new pen. If you split the dose wrong, you will inject too little or too much insulin, which can lead to too high or too low blood sugar level.
Further important information
Treat your pen with care. Rough handling or misuse may cause inaccurate dosing, which can lead to too high or too low blood sugar level.
3 City Place, Beehive Ring Road, Gatwick, West Sussex, RH6 0PA
+44 (0)1293 613535
+44 (0)800 023 2573
http://www.novonordisk.co.uk
+44 (0)1293 613555
+44 (0)800 023 2573